Ian T. Bothwell - 09 Jun 2021 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
Chief Financial Officer, Director, 10%+ Owner
Signature
/s/ Ian Bothwell
Issuer symbol
OCEL
Transactions as of
09 Jun 2021
Transactions value $
-$39,750
Form type
4
Filing time
11 Jun 2021, 21:45:18 UTC
Previous filing
08 Jun 2021
Next filing
16 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCEL Common Stock Sale -$7.35K -50K -0.03% $0.15 148M 09 Jun 2021 Direct
transaction OCEL Common Stock Sale -$4.5K -30K -0.02% $0.15 148M 09 Jun 2021 Direct
transaction OCEL Common Stock Sale -$7.1K -50K -0.03% $0.14 148M 10 Jun 2021 Direct
transaction OCEL Common Stock Sale -$14K -100K -0.07% $0.14 148M 10 Jun 2021 Direct
transaction OCEL Common Stock Sale -$5.4K -40K -0.03% $0.14 148M 11 Jun 2021 Direct
transaction OCEL Common Stock Sale -$1.4K -10K -0.01% $0.14 148M 11 Jun 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.